Thymosin β4 is a 43 amino acid peptide which is regarded as the main intracellular G-actin sequestering peptide. Extracellular thymosin β4 may contribute to physiological processes such as angiogenesis, wound healing and regulation of inflammation.
CAT# | 10-101-35 |
CAS | 77591-33-4 (net) |
Synonyms/Alias | Fx Peptide; Thymosin beta4; Thymosin beta 4; Thymosin beta(4); Thymosin β4; Tβ4; Tb4; Thymosin beta-4; Thymosin β-4; Thymosin β 4; TB-500 |
M.F/Formula | C212H350N56O78S |
M.W/Mr. | 4963.49 |
Sequence | Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH |
Labeling Target | G-actin monomers |
Application | Thymosin β4 has been tested in multicenter trials in patients with bed sores, ulcers caused by venostasis, epidermolysis bullosa simplex and chronic neurotrophic corneal epithelial defects. And it was found to promote repair. |
Biological Activity | Thymosin β4 Acetate is a 43 amino acid peptide which is regarded as the main intracellular G-actin sequestering peptide. |
Areas of Interest | Cosmetic Peptides & Dermatology Inflammation Research Regenerative Medicine |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Lecirelin, a synthetic hormone, is a strongly basic nonapeptide with sequence yr-His-Trp-Ser-Tyr-tBu-D-Gly-Leu-A ...
Icatibant, sold under the trade name Firazyr, is a plasma kallikrein inhibitor and the bradykinin B2 receptor an ...
Deslorelin acetate, marketed under the trade names Ovuplant, SucroMate and Suprelorin, is an injectable gonadotr ...
Glucagon is a 29-amino acid peptide hormone that is synthesized in pancreatic α cells from the proglucagon precursor by proho ...
Enfuvirtide, also named pentafuside, is an HIV fusion inhibitor originated at Duke University, where researchers ...